Clint Cary, MD, MPH
Associate Professor of Urology
Adjunct Lecturer, Health Policy Management, School of Public Health
- Phone
- (317) 948-9272
- Address
-
RT 420
UROL
IN
Indianapolis, IN - PubMed:
-
Bio
Dr. Cary completed his urology residency at Indiana University and then went on to complete a two year urologic oncology fellowship at the University of California, San Francisco. In addition to his fellowship, he completed a Master of Public Health Degree from U.C. Berkeley with a concentration in epidemiology. His clinical interest is in urologic oncology with a focus on the surgical managment of advanced testicular cancer and bladder cancer. His research efforts focus on health services and outcomes research in testis and bladder cancer.
Dr. Cary may be contacted for an appointment by either using the online request link, by phone at (317) 948-9272, by fax at (317) 944-0174
| Year | Degree | Institution |
|---|---|---|
| 2012 | MPH | University of California, Berkeley |
| 2011 | Fellowship | University of California, San Francisco |
| 2005 | Residency | Indiana University School of Medicine |
| 2005 | MD | University of Tennessee |
| 2001 | BS | University of Tennessee |
Dr. Cary's primary research interest involves testicular cancer. He has published numerous peer-reviewed publications describing the surgical management and outcomes in patients with advanced germ cell tumors. He is currently involved with several projects including a Pilot study in patients with clinical stage I testicular cancer to understand how they make treatment decisions. He is also the site Principal Investigator for the multi-institutional Phase II RPLND trial in patients with early metastatic seminoma.
Additionally, Dr. Cary is funded through the National Cancer Institute by a K23 Career Development Award over 5-years. His grant evaluates patterns of care in patients with non-muscle invasive bladder cancer who received mitomycin C and to develop and implement interventions to improve access to this therapy.
Finally, he is the Director of the Cancer Health Equities Center at the Indiana University Melvin and Bren Simon Cancer Center. In this role, he unites cancer researchers across IU campuses including Purdue and Notre Dame to address cancer health disparities across the state of Indiana through research, policy, and community engagement.
Cary C; Urology 2016 Sep 9
Nguyen HG; Punnen S; Cowan JE; Leapman M; Cary C; Welty C; Weinberg V; Cooperberg MR; Meng MV; Greene KL; Garcia M; Carroll PR; The Journal of urology 2016 Sep 28
Jacob JM; Cary C; Jiang S; Foster RS; House MG; Urology 2016 Sep 19
Cary C; The Journal of urology 2016 Nov 9
Jacob JM; Cary C; Foster RS; House MG; Urology 2016 Nov 7
Jacob JM; Mehan R; Beck SD; Cary C; Masterson TA; Bihrle R; Foster RS; Urology 2016 Nov 10
Cary C; Odisho AY; Cooperberg MR; Prostate cancer and prostatic diseases 2016 Jan 19
Masterson TA; Cary C; Cheng L; Expert review of anticancer therapy 2016 Feb 2
Jacob JM; Cary C; Urology 2016 Dec 26
Cary C; Pedrosa JA; Jacob J; Beck SD; Rice KR; Einhorn LH; Foster RS; Cancer 2015 Sep 15
Masterson TA; Cary C; Rice KR; Foster RS; The Urologic clinics of North America 2015 Jun 6
Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS; Urology 2015 Jul 29
Cary C; Masterson TA; Bihrle R; Foster RS; Urologic oncology 2015 Jan 5
Giannatempo P; Pond GR; Sonpavde G; Albany C; Loriot Y; Sweeney CJ; Salvioni R; Colecchia M; Nicolai N; Raggi D; Rice KR; Flack CK; El Mouallem NR; Feldman H; Fizazi K; Einhorn LH; Foster RS; Necchi A; Cary C; The Journal of urology 2015 Dec 31
Liu NW; Shatagopam K; Monn MF; Kaimakliotis HZ; Cary C; Boris RS; Mellon MJ; Masterson TA; Foster RS; Gardner TA; Bihrle R; House MG; Koch MO; Urologic oncology 2015 Aug 14
Dr. Cary's clinical interest is the surgical management of testicular cancer patients including primary and post-chemotherapy RPLND. Additionally, he performs various urinary diversions, including ileal conduit, Indiana Pouch, and neobladder for patients with muscle invasive bladder cancer as well as local and advanced kidney cancer surgery using robotic and open techniques.